Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future-Reference-Cited by-同舟云学术

Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future

Published:2022 Issue:4 Volume:51 Page:1212-1233
ISSN:0306-0012
Container-title:Chemical Society Reviews
language:en
Short-container-title:Chem. Soc. Rev.

Author:

Sen Sajal¹^ORCID,Won Miae²^ORCID,Levine Matthew S.¹,Noh Yuvin²,Sedgwick Adam C.¹^ORCID,Kim Jong Seung²^ORCID,Sessler Jonathan L.¹^ORCID,Arambula Jonathan F.¹³^ORCID

Affiliation:

1. Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712-1224, USA

2. Department of Chemistry, Korea University, Seoul 02841, Korea

3. OncoTEX, Inc. 3800 North Lamar Blvd., Austin, Texas 78756, USA

Abstract

Immunogenic cell death (ICD) is a unique mode of cell death that could trigger tumour-specific immune response. Metal-based drugs which have emerged as promising agents within the lexicon of possible ICD inducers will be the topic of this review.

Funder

National Research Foundation of Korea

National Cancer Institute

Welch Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/CS/D1CS00417D

Reference72 articles.

1. Immunogenic cell death in cancer and infectious disease